GSK logo linking to the homepage Menu ViiV Healthcare 100% focussed on HIV. View video on YouTube Advancing HIV research Since the 1980s when scientists at Burroughs Wellcome – a predecessor company to GSK – developed AZT, the first medicine for the treatment of HIV, there have been significant advances in HIV therapy and it can now be considered a chronic condition. And yet many treatment related needs persist, as people living with HIV are required to remain on antiretroviral treatment for life. New innovative treatment options are still needed to support a broad range of people living with HIV. That’s why scientists at ViiV Healthcare are researching new treatment options and ways to reduce the impact from prolonged HIV treatment, exploring new treatment delivery technologies and formulations that can help prevent HIV infection. Supporting the global community Beyond the scientists investigating new treatment options for HIV, specialist teams from ViiV Healthcare are working to address gaps in HIV care by listening to and engaging with people living with HIV, healthcare providers and policy makers – to understand their challenges and promote a collaborative response by the global community to HIV. Meet Juno and Sophie Juno is a gregarious and outgoing 52 year old transgender woman, living with HIV. Together with her friend Sophie, who also has HIV, they ardently believe that “knowledge is power” when it comes to living well with HIV and finding the right antiretroviral treatment for their own circumstances. This is their story. View video on YouTube Working with hundreds of community groups and patient organisations all over the world through its Positive Action programmes, ViiV Healthcare is also supporting vulnerable communities who are most severely impacted by HIV. ViiV Healthcare’s ultimate goal is to end the HIV epidemic. This ambitious goal reflects the company’s commitment to people living with HIV and the healthcare professionals who treat them. Connect with ViiV Healthcare on Twitter Facebook YouTube LinkedIn GSK Quick links Behind the science About us Products Careers Investors Media Research Responsibility Legal Terms of use Cookie policy Privacy Notice Modern Slavery Act statement 2017 PDF - 199.6KB Accessibility Sitemap Accessibility Contact us Contact us Partnerships Report a possible side effect Business to business Supplier website Business to business © 2001-2018 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.